FRIDAY, July 11, 2025 (HealthDay News) — Global deaths from AIDS have dropped to their lowest levels in more than 30 years, ...

There is widespread hope for curbing HIV after the United States Food and Drug Administration (FDA) approved an injectable ...

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

In an interview with The News & Observer, Dr. Barton Haynes talks future of HIV vaccine development after HHS canceled the ...

A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...

A report released by the United Nations revealed that US funding cuts could significantly increase the mortality rate to four ...

Known as the President's Emergency Plan for Aids Relief (Pepfar), it led to the investment of more than $100bn (£74bn) in the ...

Cuts to U.S. foreign aid will endanger HIV treatment and prevention services globally and are likely to reverse decades of ...

Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care   The Big Story Global HIV program a ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...